인문학
사회과학
자연과학
공학
의약학
농수해양학
예술체육학
복합학
개인구독
소속 기관이 없으신 경우, 개인 정기구독을 하시면 저렴하게
논문을 무제한 열람 이용할 수 있어요.
지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
초록·키워드
The quantitative assessment of preoperative liver function is essential since hepatic reserve function after hepatic resection has significant influence on the prognosis. But conventional liver function tests are limited in quantitating hepatic function and can only assess the presence or absence of hepatobiliary injury without reflecting the severity of the disease. More recently, measurements of hepatic lidocaine metabolism to its primary metabolite monoethylglycinexylidide(MEGX) taken by an automated fluorescent polarization immunoassay with a TDx analyzer(Abbott Laboratories, Diagnostic Division, North Chicago, IL) have demonstrated a means for a rapid and reproducible assessment of hepatic function. Therefore, to determine the clinical value of this lidocaine metabolite as a quantitative liver function test, we measured the serum MEGX concentration, 15 min after intravenous administration of single dose of lidocaine (1mg/kg) in 40 adults. The following side effects were recorded: dizziness(N=39), tinnitus(N=39), perioral numbness(N=3), and febrile sensation(N=1). These side effects were mild, disappearing within 5 minutes. 6 of 40 cases were excluded due to abnormal liver function and/or very low MEGX concentrations(less than 10 percentile). The peak MEGX concentration of 34 cases, 15 min after injection of lidocaine, was 431.8 ±14.74 ng/ml(mean S.E) with the reference value between from 35.47 and 51.80 ng/ml(25-75 percentile). The measurement of MEGX concentration, 15 min after lidocaine injection, may serve as a simple, safe, and rapid quantitative liver function test; but further prospective studies in cases with chronic hepatitis and primary hepatoma are needed in order to establish the cutoff level of MEGX concentration that can determine the abnormality.
본문·목차
인공지능 문자 인식 모델을 통해 추출된 텍스트로, 일부 오타나 오류가 포함될 수 있으나 지속적으로 개선 중입니다.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
오류를 발견하셨다면 해당 부분을 드래그한 후 ' 를 통해 신고해주세요.
최근 본 자료 전체보기
UCI(KEPA) : I410-ECN-0101-2014-514-001249181